A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
Corticosteroids are one of the mainstays of treatment for subjects with
corticosteroid-responsive dermatoses such as psoriasis. This study has been designed to
determine and compare the efficacy and safety of a formulation of 122-0551 versus the
corresponding Vehicle in subjects with stable plaque psoriasis after twice daily dosing for
14 consecutive days.